National Marrow Donor Program

Analysis

National Marrow Donor Program is a registered charity in United States, based in Minneapolis, MN. It received its IRS tax-exemption ruling in May 1989, 37 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending September 2023, National Marrow Donor Program reported income of $578.0m and spending of $571.2m, spending 99% of its income. Across the 5 years on record, from September 2019 to September 2023, income grew from $445.4m to $578.0m (+30%), an average of +6.7% a year. The sharpest change came in the year to September 2023, when income rose by 15%. Over the whole period it spent 100% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Marrow Donor Program sits at the 99th percentile: it is larger than about 99% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within MN. Charities of a similar size with the same main cause include Our Lady of Lourdes Regional Medical Center Inc ($577.7m), Emanate Health Medical Center ($579.6m) and Prohealth Waukesha Memorial Hospital Inc ($577.3m).

On its Form 990 for the period ending September 2023, revenue came from contributions and grants 10% and program service revenue 88% of the total. Compensation of current officers, directors and key employees was $6.6m (1.1% of expenses). Other salaries and wages came to $162.9m. At year end it held assets of $352.3m against liabilities of $154.8m, net assets of $197.5m. It reported 1,651 employees.